Takayuki Ikezoe

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Topics

Venous Thromboembolism

Obstructive Sleep Apnea

Inflammatory Response

Recombinant Human

Top Venues

International journal of hematology

Science signaling

Thrombosis journal

This page only lists publications with an associated author ORCID identifier.

Publications

Noriaki Kawano, Masahiko Fukatsu, Kazuma Yamakawa, Yoshinobu Seki, Hideo Wada, Kohji Okamoto, Takayuki Ikezoe
A systematic review and meta-analysis of recombinant human soluble thrombomodulin for the treatment of DIC associated with hematological malignancies. International journal of hematology 119 (4) (2024)
Takayuki Ikezoe
Cancer-associated thrombosis and bleeding. International journal of hematology 119 (5) (2024)
Naoshi Obara, Kensuke Usuki, Takeshi Hayashi, Masato Fujii, Takayuki Ikezoe
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors. International journal of hematology 119 (3) (2024)
Naoshi Obara, Kensuke Usuki, Takeshi Hayashi, Masato Fujii, Takayuki Ikezoe
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors. International journal of hematology 119 (3) (2024)
Naoshi Obara, Kensuke Usuki, Takeshi Hayashi, Masato Fujii, Takayuki Ikezoe
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors. International journal of hematology 119 (3) (2024)
Takayuki Ikezoe
Cancer-associated thrombosis and bleeding. International journal of hematology (2024)
Naoshi Obara, Kensuke Usuki, Takeshi Hayashi, Masato Fujii, Takayuki Ikezoe
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors. International journal of hematology 119 (3) (2024)
Takayuki Ikezoe
Cancer-associated thrombosis and bleeding. International journal of hematology 119 (5) (2024)
Naoshi Obara, Kensuke Usuki, Takeshi Hayashi, Masato Fujii, Takayuki Ikezoe
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors. International journal of hematology 119 (3) (2024)
Takayuki Ikezoe
Cancer-associated thrombosis and bleeding. International journal of hematology 119 (5) (2024)
Noriaki Kawano, Masahiko Fukatsu, Kazuma Yamakawa, Yoshinobu Seki, Hideo Wada, Kohji Okamoto, Takayuki Ikezoe
A systematic review and meta-analysis of recombinant human soluble thrombomodulin for the treatment of DIC associated with hematological malignancies. International journal of hematology (2024)
Takayuki Ikezoe
Cancer-associated thrombosis and bleeding. International journal of hematology 119 (5) (2024)
Naoshi Obara, Kensuke Usuki, Takeshi Hayashi, Masato Fujii, Takayuki Ikezoe
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors. International journal of hematology (2024)
Noriaki Kawano, Masahiko Fukatsu, Kazuma Yamakawa, Yoshinobu Seki, Hideo Wada, Kohji Okamoto, Takayuki Ikezoe
A systematic review and meta-analysis of recombinant human soluble thrombomodulin for the treatment of DIC associated with hematological malignancies. International journal of hematology 119 (4) (2024)
Cong Liu, Qiu Lan, Shuo Cao, Fei Zheng, Yiwen Liang, Jingyi Shen, Ying Wang, Takayuki Ikezoe, Kailin Xu, Bin Pan
Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15. Leukemia 38 (6) (2024)
Naoshi Obara, Kensuke Usuki, Takeshi Hayashi, Masato Fujii, Takayuki Ikezoe
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors. International journal of hematology 119 (3) (2024)
Cong Liu, Qiu Lan, Shuo Cao, Fei Zheng, Yiwen Liang, Jingyi Shen, Ying Wang, Takayuki Ikezoe, Kailin Xu, Bin Pan
Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15. Leukemia 38 (6) (2024)
Cong Liu, Qiu Lan, Shuo Cao, Fei Zheng, Yiwen Liang, Jingyi Shen, Ying Wang, Takayuki Ikezoe, Kailin Xu, Bin Pan
Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15. Leukemia (2024)
Naoshi Obara, Kensuke Usuki, Takeshi Hayashi, Masato Fujii, Takayuki Ikezoe
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors. International journal of hematology 119 (3) (2024)
Takahiro Sano, Koki Ueda, Keiji Minakawa, Tsutomu Mori, Yuko Hashimoto, Haruhiko Koseki, Yasuchika Takeishi, Kazuhiko Ikeda, Takayuki Ikezoe
Impaired Repopulating Ability of Uhrf2 -/- Hematopoietic Progenitor Cells in Mice. Genes 14 (8) (2023)
Masahiko Fukatsu, Yoichi Hamazaki, Yuki Sato, Daisuke Koyama, Takayuki Ikezoe
A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D. International journal of hematology (2023)
Masahiko Fukatsu, Hiroshi Ohkawara, Xintao Wang, Lobna Alkebsi, Miki Furukawa, Hirotaka Mori, Miwa Fukami, Shin-Ichi Fukami, Takahiro Sano, Hiroshi Takahashi, Kayo Harada-Shirado, Satoshi Kimura, Koichi Sugimoto, Kazuei Ogawa, Takayuki Ikezoe
The suppressive effects of Mer inhibition on inflammatory responses in the pathogenesis of LPS-induced ALI/ARDS. Science signaling 15 (724) (2022)
Hirotaka Mori, Yuki Kataoka, Kayo Harada-Shirado, Noriaki Kawano, Mineji Hayakawa, Yoshinobu Seki, Toshimasa Uchiyama, Kazuma Yamakawa, Hiroyasu Ishikura, Yuhei Irie, Kenji Nishio, Noritaka Yada, Kohji Okamoto, Shingo Yamada, Takayuki Ikezoe
Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study. Thrombosis journal 20 (1) (2022)
Takayuki Ikezoe, Hideyoshi Noji, Yasutaka Ueda, Yoshinobu Kanda, Shinichiro Okamoto, Kensuke Usuki, Takahisa Matsuda, Hirozumi Akiyama, Akihiko Shimono, Yuji Yonemura, Tatsuya Kawaguchi, Shigeru Chiba, Yuzuru Kanakura, Jun-Ichi Nishimura, Haruhiko Ninomiya, Naoshi Obara
Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan. International journal of hematology 115 (4) (2022)
Hirotaka Mori, Hiroshi Ohkawara, Ryuichi Togawa, Mami Rikimaru, Yoko Shibata, Takayuki Ikezoe
Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review. International journal of hematology 113 (3) (2021)
Seiji Madoiwa, Goichi Honda, Noriaki Kawano, Toshimasa Uchiyama, Kazuo Kawasugi, Naoki Takezako, Kei Suzuki, Yoshinobu Seki, Takayuki Ikezoe, Kohji Okamoto, Hideo Wada
An evaluation of the Japanese Society on Thrombosis and Hemostasis criteria for disseminated intravascular coagulation as a predictor of prognosis in patients with infection. International journal of laboratory hematology 43 (6) (2021)
Takayuki Ikezoe
Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies. International journal of hematology 113 (1) (2020)